References
1. Warshaw AL, del Castillo CF. Pancreatic carcinoma. N Engl J Med.
1992; 326:455–465.
2. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997;
349:485–489.
3. Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry;
30th year anniversary: Japan Pancreas Society. Pancreas 2012;
41:985–992.
4. Kanno A, Masamune A, Hanada K, et al; Japan Study Group on the Early
Detection of Pancreatic Cancer (JEDPAC). Multicenter study of early
pancreatic cancer in Japan. Pancreatology 2018; 18:61–67.
5. Yamaguchi K, Okusaka T, Shimizu K, et al; Committee for Revision of
Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society.
Clinical practice guidelines for pancreatic cancer 2016 from the Japan
Pancreas Society: a synopsis. Pancreas 2017; 46:595–604.
6. Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using
endoscopic nasopancreatic drainage for early diagnosis of pancreatic
cancer: establishing a new method for the early detection of pancreatic
carcinoma in situ. Pancreas 2012; 41:523–529.
7. Kikuyama M, Hanada K, Ueki T. Pancreatic carcinoma in situ presenting
prominent fatty change of the pancreatic body on CT: experiences from 3
cases. In Japanese with English Abstract. Suizo 2015; 30:626–632.
8. Miyata T, Takenaka M, Omoto S, et al. A case of pancreatic carcinoma
in situ diagnosed by repeated pancreatic juice cytology. Oncology 2017;
93:98–101.
9. Hanada K, Okazaki A, Hirano N, et al. Diagnostic strategies for early
pancreatic cancer. J. Gastroenterol 2015; 50:147–154.
10. Seki M, Ninomiya E, Takano K, et al. Pancreatogram findings for
carcinoma in situ (CIS) of the pancreas seen on endoscopic retrograde
cholangiopancreatography and postoperative pancreatography of resected
specimens: can CIS be diagnosed preoperatively? Pancreatology 2008;
8:142–152.
11. Ikeda M, Yanagisawa A, Seki M, et al. The early state of invasive
pancreatic ductal adenocarcinomas: characteristics of the low papillary
type and flat type intraductal carcinoma. Pancreas 2006; 33:135–141.
12. Uesaka K, Boku N, Fukutom A, et al.: JASPAC 01 Study Group. Adjuvant
chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a
phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Lancet 2016; 388:248–257.
13. Sugita H, Kuroki H, Akiyama T, et al. Hand-assisted laparoscopic
spleen-preserving distal pancreatectomy combined with laparoscopic
distal gastrectomy for the treatment of pancreatic neuroendocrine tumor
with early gastric cancer: Report of a case. Int J Surg Case
Rep. 2016; 28: 258–261.